These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 23422352)
1. Recombinant streptavidin-C3bot for delivery of proteins into macrophages. Christow H; Lillich M; Sold A; Fahrer J; Barth H Toxicon; 2013 Dec; 75():144-7. PubMed ID: 23422352 [TBL] [Abstract][Full Text] [Related]
2. A recombinant fusion toxin based on enzymatic inactive C3bot1 selectively targets macrophages. Dmochewitz L; Förtsch C; Zwerger C; Vaeth M; Felder E; Huber-Lang M; Barth H PLoS One; 2013; 8(1):e54517. PubMed ID: 23349915 [TBL] [Abstract][Full Text] [Related]
3. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells. Fahrer J; Plunien R; Binder U; Langer T; Seliger H; Barth H Bioconjug Chem; 2010 Jan; 21(1):130-9. PubMed ID: 20030334 [TBL] [Abstract][Full Text] [Related]
4. The C2-streptavidin delivery system promotes the uptake of biotinylated molecules in macrophages and T-leukemia cells. Fahrer J; Rieger J; van Zandbergen G; Barth H Biol Chem; 2010 Nov; 391(11):1315-25. PubMed ID: 20868225 [TBL] [Abstract][Full Text] [Related]
5. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization. Wilde C; Vogelsgesang M; Aktories K Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311 [TBL] [Abstract][Full Text] [Related]
6. Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes. Fahrer J; Kuban J; Heine K; Rupps G; Kaiser E; Felder E; Benz R; Barth H Cell Microbiol; 2010 Feb; 12(2):233-47. PubMed ID: 19840027 [TBL] [Abstract][Full Text] [Related]
7. Streptavidin-conjugated C3 protein mediates the delivery of mono-biotinylated RNAse A into macrophages. Lillich M; Chen X; Weil T; Barth H; Fahrer J Bioconjug Chem; 2012 Jul; 23(7):1426-36. PubMed ID: 22681511 [TBL] [Abstract][Full Text] [Related]
8. Fellermann M; Stemmer M; Noschka R; Wondany F; Fischer S; Michaelis J; Stenger S; Barth H Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287979 [TBL] [Abstract][Full Text] [Related]
9. Rho-inhibiting C2IN-C3 fusion toxin inhibits chemotactic recruitment of human monocytes ex vivo and in mice in vivo. Martin T; Möglich A; Felix I; Förtsch C; Rittlinger A; Palmer A; Denk S; Schneider J; Notbohm L; Vogel M; Geiger H; Paschke S; Huber-Lang M; Barth H Arch Toxicol; 2018 Jan; 92(1):323-336. PubMed ID: 28924833 [TBL] [Abstract][Full Text] [Related]
10. A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. Höltje M; Djalali S; Hofmann F; Münster-Wandowski A; Hendrix S; Boato F; Dreger SC; Grosse G; Henneberger C; Grantyn R; Just I; Ahnert-Hilger G FASEB J; 2009 Apr; 23(4):1115-26. PubMed ID: 19047066 [TBL] [Abstract][Full Text] [Related]
11. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme. Vogelsgesang M; Aktories K Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778 [TBL] [Abstract][Full Text] [Related]
12. Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174Q. Rohrbeck A; Kolbe T; Hagemann S; Genth H; Just I FEBS J; 2012 Aug; 279(15):2657-71. PubMed ID: 22621765 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of macrophage migration by C. botulinum exoenzyme C3. Rotsch J; Rohrbeck A; May M; Kolbe T; Hagemann S; Schelle I; Just I; Genth H; Huelsenbeck SC Naunyn Schmiedebergs Arch Pharmacol; 2012 Sep; 385(9):883-90. PubMed ID: 22644106 [TBL] [Abstract][Full Text] [Related]
14. Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin. Fahrer J; Funk J; Lillich M; Barth H Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):263-73. PubMed ID: 21136248 [TBL] [Abstract][Full Text] [Related]
15. Spatiotemporally Controlled Release of Rho-Inhibiting C3 Toxin from a Protein-DNA Hybrid Hydrogel for Targeted Inhibition of Osteoclast Formation and Activity. Gačanin J; Kovtun A; Fischer S; Schwager V; Quambusch J; Kuan SL; Liu W; Boldt F; Li C; Yang Z; Liu D; Wu Y; Weil T; Barth H; Ignatius A Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28758712 [TBL] [Abstract][Full Text] [Related]
16. A Supramolecular Approach toward Bioinspired PAMAM-Dendronized Fusion Toxins. Kuan SL; Förtsch C; Ng DY; Fischer S; Tokura Y; Liu W; Wu Y; Koynov K; Barth H; Weil T Macromol Biosci; 2016 Jun; 16(6):803-10. PubMed ID: 26833574 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. Han S; Arvai AS; Clancy SB; Tainer JA J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250 [TBL] [Abstract][Full Text] [Related]
19. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs. Barth H; Blöcker D; Aktories K Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490 [TBL] [Abstract][Full Text] [Related]
20. ADP-ribosylation of the rho/rac gene products by botulinum ADP-ribosyltransferase: identity of the enzyme and effects on protein and cell functions. Narumiya S; Morii N; Sekine A; Kozaki S J Physiol (Paris); 1990; 84(4):267-72. PubMed ID: 2127805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]